COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

被引:1
|
作者
Sen, Selcuk [1 ]
Uresin, Ali Yagiz [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Div Clin Pharmacol, Dept Med Pharmacol, Istanbul, Turkey
关键词
ACE2;
D O I
10.5543/tkda.2020.64072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
下载
收藏
页码:631 / 634
页数:4
相关论文
共 50 条
  • [42] Clinical research and COVID-19: Science is not an option
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E72 - E73
  • [43] Doxycycline: a new treatment option for COVID-19
    Anwar, Ismail
    Anwer, Eman Kamal El-dien
    AbdAllah, Mohamed
    ALEXANDRIA JOURNAL OF MEDICINE, 2020, 56 (01) : 130 - 131
  • [44] Remdesivir as a possible therapeutic option for the COVID-19
    Al-Tawfiq, Jaffar A.
    Al-Homoud, Ali H.
    Memish, Ziad A.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
  • [45] The COVID-19 risk in the Chinese option market
    Li, Jianhui
    Ruan, Xinfeng
    Gehricke, Sebastian A.
    Zhang, Jin E.
    INTERNATIONAL REVIEW OF FINANCE, 2022, 22 (02) : 346 - 355
  • [46] Clinical research and COVID-19: science is not an option
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (07): : 710 - 711
  • [47] A Shot in the Dark!: RAAS Inhibitors Cause Severe COVID-19 Infection
    Krishna, Bhuvana
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (04) : 353 - 354
  • [48] Stem cells as an option for the treatment of COVID-19
    Maria Veronica Cuevas-González
    Juan Carlos Cuevas-González
    World Journal of Clinical Cases, 2022, 10 (18) : 6338 - 6340
  • [49] Thymalin as an immunomodulation option in severe COVID-19
    Lukyanov, Sergey
    Shapovalov, Konstantine
    Tereshkov, Pavel
    Smolyakov, Yuri
    Vanchikova, Ayagma
    Kuznik, Boris
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [50] Stem cells as an option for the treatment of COVID-19
    Veronica Cuevas-Gonzalez, Maria
    Carlos Cuevas-Gonzalez, Juan
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (18) : 6338 - 6340